TY - JOUR
T1 - Risk factors for healthcare personnel infection with endemic coronaviruses (HKU1, OC43, NL63, 229E)
T2 - Results from the Respiratory Protection Effectiveness clinical Trial (RESPECT)
AU - Cummings, Derek A.T.
AU - Radonovich, Lewis J.
AU - Gorse, Geoffrey J.
AU - Gaydos, Charlotte A.
AU - Bessesen, Mary T.
AU - Brown, Alexandria C.
AU - Gibert, Cynthia L.
AU - Hitchings, Matthew D.T.
AU - Lessler, Justin
AU - Nyquist, Ann Christine
AU - Rattigan, Susan M.
AU - Rodriguez-Barradas, Maria C.
AU - Price, Connie Savor
AU - Reich, Nicholas G.
AU - Simberkoff, Michael S.
AU - Perl, Trish M.
N1 - Funding Information:
This work was supported by the CDC (grant number 75D30119P04741) to D. A. T. C., S. M. R., and M. D. T. H. ResPECT was funded by the CDC, the Veterans Health Administration, and the Biodefense Advanced Research and Development Agency.
Publisher Copyright:
© The Author(s) 2020.
PY - 2021/12/1
Y1 - 2021/12/1
N2 - Background. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents a large risk to healthcare personnel (HCP). Quantifying the risk of coronavirus infection associated with workplace activities is an urgent need. Methods. We assessed the association of worker characteristics, occupational roles and behaviors, and participation in procedures with the risk of endemic coronavirus infection among HCP who participated in the Respiratory Protection Effectiveness Clinical Trial (ResPECT), a cluster randomized trial to assess personal protective equipment to prevent respiratory infections and illness conducted from 2011 to 2016. Results. Among 4689 HCP seasons, we detected coronavirus infection in 387 (8%). HCP who participated in an aerosol-generating procedure (AGP) at least once during the viral respiratory season were 105% (95% confidence interval, 21%–240%) more likely to be diagnosed with a laboratory-confirmed coronavirus infection. Younger individuals, those who saw pediatric patients, and those with household members <5 years of age were at increased risk of coronavirus infection. Conclusions. Our analysis suggests that the risk of HCP becoming infected with an endemic coronavirus increases approximately 2-fold with exposures to AGPs. Our findings may be relevant to the coronavirus disease 2019 (COVID-19) pandemic; however, SARS-CoV-2, the virus that causes COVID-19, may differ from endemic coronaviruses in important ways.
AB - Background. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents a large risk to healthcare personnel (HCP). Quantifying the risk of coronavirus infection associated with workplace activities is an urgent need. Methods. We assessed the association of worker characteristics, occupational roles and behaviors, and participation in procedures with the risk of endemic coronavirus infection among HCP who participated in the Respiratory Protection Effectiveness Clinical Trial (ResPECT), a cluster randomized trial to assess personal protective equipment to prevent respiratory infections and illness conducted from 2011 to 2016. Results. Among 4689 HCP seasons, we detected coronavirus infection in 387 (8%). HCP who participated in an aerosol-generating procedure (AGP) at least once during the viral respiratory season were 105% (95% confidence interval, 21%–240%) more likely to be diagnosed with a laboratory-confirmed coronavirus infection. Younger individuals, those who saw pediatric patients, and those with household members <5 years of age were at increased risk of coronavirus infection. Conclusions. Our analysis suggests that the risk of HCP becoming infected with an endemic coronavirus increases approximately 2-fold with exposures to AGPs. Our findings may be relevant to the coronavirus disease 2019 (COVID-19) pandemic; however, SARS-CoV-2, the virus that causes COVID-19, may differ from endemic coronaviruses in important ways.
KW - 229E
KW - Aerosol generating procedure
KW - Coronavirus
KW - HKU1
KW - NL63
KW - OC43
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=85122546756&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122546756&partnerID=8YFLogxK
U2 - 10.1093/cid/ciaa900
DO - 10.1093/cid/ciaa900
M3 - Article
C2 - 32645144
AN - SCOPUS:85122546756
SN - 1058-4838
VL - 73
SP - E4428-E4432
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 11
ER -